Drug from Mediterranean weed kills tumor cells in mice – Thapsia garganica

Just a three-day course  reduced the size of human prostate tumors grown in mice by an average of 50 percent within 30 days

‘Molecular grenade’ now in clinical trials for advanced cancer

12 JUL 2012

Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel — undetected by normal cells — through the bloodstream until activated by specific cancer proteins. The drug, made from a weedlike plant, has been shown to destroy cancers and their direct blood supplies, acting like a “molecular grenade,” and sparing healthy blood vessels and tissues.

In laboratory studies, researchers said they found that a three-day course of the drug, called G202, reduced the size of human prostate tumors grown in mice by an average of 50 percent within 30 days. In a direct comparison, G202 outperformed the chemotherapy drug docetaxel, reducing seven of nine human prostate…